Literature DB >> 29982376

Antimicrobial Stewardship and Intensive Care Unit Mortality: A Systematic Review.

Patrick J Lindsay1, Sagar Rohailla1, Linda R Taggart1,2, David Lightfoot2, Thomas Havey3, Nick Daneman4, Christopher Lowe5,6, Matthew P Muller1,2.   

Abstract

BACKGROUND: Antimicrobial stewardship programs (ASPs) using audit and feedback in the intensive care unit (ICU) setting can reduce harms related to inappropriate antibiotic use. However, inappropriate discontinuation or narrowing of antibiotic treatment could increase infection-related mortality in this population. Individual ASP studies are underpowered to detect differences in mortality.
METHODS: We conducted a systematic review and meta-analysis of audit and feedback in the ICU setting, using mortality as our outcome.
RESULTS: Of 2447 citations, 11 studies met our inclusion criteria. Although a variety of study designs were used to assess reductions in antibiotic use, mortality was analyzed using an uncontrolled before-after study design in all studies. Five studies directed audit and feedback to all or most ICU patients receiving antibiotics and measured overall ICU mortality. In the meta-analysis of these studies, the pooled relative risk of ICU mortality was 1.03 (95% confidence interval, .93-1.14). A second meta-analysis of 3 smaller studies that evaluated mortality only in patients directly assessed by the ASP found a pooled relative risk of ICU mortality of 1.06 (95% confidence interval, .80 to 1.4). Three studies were not appropriate for meta-analysis, but their results were consistent with our overall findings.
CONCLUSIONS: Our systematic review did not identify a change in mortality associated with antimicrobial stewardship using audit and feedback in the ICU setting. These results increase our confidence that audit and feedback can be safely implemented in this setting. Future studies should report standardized estimates of mortality and use more robust study designs to assess mortality, when feasible.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antimicrobial stewardship program; intensive care unit; mortality

Mesh:

Substances:

Year:  2019        PMID: 29982376     DOI: 10.1093/cid/ciy550

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Antibiotic Thresholds for Sepsis and Septic Shock.

Authors:  Marin H Kollef; Jason P Burnham
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

2.  Physician Responsiveness to Positive Blood Culture Results at the Minneapolis Veterans Affairs Hospital-Is Anyone Paying Attention?

Authors:  Shaun Heimbichner Johnson; Steven James Waisbren
Journal:  Fed Pract       Date:  2021-03

3.  Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study.

Authors:  Philippe Guerci; Hugo Bellut; Mokhtar Mokhtari; Julie Gaudefroy; Nicolas Mongardon; Claire Charpentier; Guillaume Louis; Parvine Tashk; Clément Dubost; Stanislas Ledochowski; Antoine Kimmoun; Thomas Godet; Julien Pottecher; Jean-Marc Lalot; Emmanuel Novy; David Hajage; Adrien Bouglé
Journal:  Crit Care       Date:  2019-11-21       Impact factor: 9.097

4.  Time to blood, respiratory and urine culture positivity in the intensive care unit: Implications for de-escalation.

Authors:  Lindsey A Sellers; Kathryn M Fitton; Margaret F Segovia; Christy C Forehand; Kevin K Dobbin; Andrea Sikora Newsome
Journal:  SAGE Open Med       Date:  2021-08-19

5.  Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs.

Authors:  Mera A Ababneh; Mohammad Al Domi; Abeer M Rababa'h
Journal:  Heliyon       Date:  2022-08-04

6.  Bibliometric analysis of peer-reviewed literature on antimicrobial stewardship from 1990 to 2019.

Authors:  Waleed M Sweileh
Journal:  Global Health       Date:  2021-01-04       Impact factor: 4.185

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.